BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 25187947)

  • 1. Baseline CD4+ T cell counts correlates with HIV-1 synonymous rate in HLA-B*5701 subjects with different risk of disease progression.
    Norström MM; Veras NM; Huang W; Proper MC; Cook J; Hartogensis W; Hecht FM; Karlsson AC; Salemi M
    PLoS Comput Biol; 2014 Sep; 10(9):e1003830. PubMed ID: 25187947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of immune and viral factors distinguishes low-risk versus high-risk HIV-1 disease progression in HLA-B*5701 subjects.
    Norström MM; Buggert M; Tauriainen J; Hartogensis W; Prosperi MC; Wallet MA; Hecht FM; Salemi M; Karlsson AC
    J Virol; 2012 Sep; 86(18):9802-16. PubMed ID: 22761389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid HIV disease progression following superinfection in an HLA-B*27:05/B*57:01-positive transmission recipient.
    Brener J; Gall A; Hurst J; Batorsky R; Lavandier N; Chen F; Edwards A; Bolton C; Dsouza R; Allen T; Pybus OG; Kellam P; Matthews PC; Goulder PJR
    Retrovirology; 2018 Jan; 15(1):7. PubMed ID: 29338738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low Postseroconversion CD4
    Palm AA; Lemey P; Jansson M; Månsson F; Kvist A; Szojka Z; Biague A; da Silva ZJ; Rowland-Jones SL; Norrgren H; Esbjörnsson J; Medstrand P
    mBio; 2019 Jan; 10(1):. PubMed ID: 30622192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of HLA selection pressure on HIV fitness at a population level in Mexico and Barbados.
    Juarez-Molina CI; Payne R; Soto-Nava M; Avila-Rios S; Valenzuela-Ponce H; Adland E; Leitman E; Brener J; Muenchhoff M; Branch S; Landis C; Reyes-Teran G; Goulder P
    J Virol; 2014 Sep; 88(18):10392-8. PubMed ID: 25008926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pol-Driven Replicative Capacity Impacts Disease Progression in HIV-1 Subtype C Infection.
    Ojwach DBA; MacMillan D; Reddy T; Novitsky V; Brumme ZL; Brockman MA; Ndung'u T; Mann JK
    J Virol; 2018 Oct; 92(19):. PubMed ID: 29997209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of HLA-B*52:01-Driven Escape Mutations on Viral Replicative Capacity.
    Tsai MC; Singh S; Adland E; Goulder P
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32321820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-B*57 elite suppressor and chronic progressor HIV-1 isolates replicate vigorously and cause CD4+ T cell depletion in humanized BLT mice.
    Salgado M; Swanson MD; Pohlmeyer CW; Buckheit RW; Wu J; Archin NM; Williams TM; Margolis DM; Siliciano RF; Garcia JV; Blankson JN
    J Virol; 2014 Mar; 88(6):3340-52. PubMed ID: 24390323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological control of chronic HIV-1 infection: HLA-mediated immune function and viral evolution in adolescents.
    Bansal A; Yue L; Conway J; Yusim K; Tang J; Kappes J; Kaslow RA; Wilson CM; Goepfert PA
    AIDS; 2007 Nov; 21(18):2387-97. PubMed ID: 18025875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of a significant impact of Gag-Protease-mediated HIV-1 replication capacity on clinical parameters in treatment-naive Japanese individuals.
    Sakai K; Chikata T; Brumme ZL; Brumme CJ; Gatanaga H; Oka S; Takiguchi M
    Retrovirology; 2015 Nov; 12():98. PubMed ID: 26585907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional avidity and IL-2/perforin production is linked to the emergence of mutations within HLA-B*5701-restricted epitopes and HIV-1 disease progression.
    Buggert M; Norström MM; Salemi M; Hecht FM; Karlsson AC
    J Immunol; 2014 May; 192(10):4685-96. PubMed ID: 24740510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gag-protease-mediated replication capacity in HIV-1 subtype C chronic infection: associations with HLA type and clinical parameters.
    Wright JK; Brumme ZL; Carlson JM; Heckerman D; Kadie CM; Brumme CJ; Wang B; Losina E; Miura T; Chonco F; van der Stok M; Mncube Z; Bishop K; Goulder PJ; Walker BD; Brockman MA; Ndung'u T
    J Virol; 2010 Oct; 84(20):10820-31. PubMed ID: 20702636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consequences of HLA-B*13-Associated Escape Mutations on HIV-1 Replication and Nef Function.
    Shahid A; Olvera A; Anmole G; Kuang XT; Cotton LA; Plana M; Brander C; Brockman MA; Brumme ZL
    J Virol; 2015 Nov; 89(22):11557-71. PubMed ID: 26355081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV immune escape at an immunodominant epitope in HLA-B*27-positive individuals predicts viral load outcome.
    Ammaranond P; van Bockel DJ; Petoumenos K; McMurchie M; Finlayson R; Middleton MG; Davenport MP; Venturi V; Suzuki K; Gelgor L; Kaldor JM; Cooper DA; Kelleher AD
    J Immunol; 2011 Jan; 186(1):479-88. PubMed ID: 21115730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High intrapatient HIV-1 evolutionary rate is associated with CCR5-to-CXCR4 coreceptor switch.
    Mild M; Gray RR; Kvist A; Lemey P; Goodenow MM; Fenyö EM; Albert J; Salemi M; Esbjörnsson J; Medstrand P
    Infect Genet Evol; 2013 Oct; 19():369-77. PubMed ID: 23672855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early selection in Gag by protective HLA alleles contributes to reduced HIV-1 replication capacity that may be largely compensated for in chronic infection.
    Brockman MA; Brumme ZL; Brumme CJ; Miura T; Sela J; Rosato PC; Kadie CM; Carlson JM; Markle TJ; Streeck H; Kelleher AD; Markowitz M; Jessen H; Rosenberg E; Altfeld M; Harrigan PR; Heckerman D; Walker BD; Allen TM
    J Virol; 2010 Nov; 84(22):11937-49. PubMed ID: 20810731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of HIV non-progression; robust and sustained CD4+ T-cell proliferative responses to p24 antigen correlate with control of viraemia and lack of disease progression after long-term transfusion-acquired HIV-1 infection.
    Dyer WB; Zaunders JJ; Yuan FF; Wang B; Learmont JC; Geczy AF; Saksena NK; McPhee DA; Gorry PR; Sullivan JS
    Retrovirology; 2008 Dec; 5():112. PubMed ID: 19077215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of the HIV-1 nef gene in HLA-B*57 positive elite suppressors.
    Salgado M; Brennan TP; O'Connell KA; Bailey JR; Ray SC; Siliciano RF; Blankson JN
    Retrovirology; 2010 Nov; 7():94. PubMed ID: 21059238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 replication fitness of HLA-B*57/58:01 CTL escape variants is restored by the accumulation of compensatory mutations in gag.
    Gijsbers EF; Feenstra KA; van Nuenen AC; Navis M; Heringa J; Schuitemaker H; Kootstra NA
    PLoS One; 2013; 8(12):e81235. PubMed ID: 24339913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal association of HLA-B*81:01- and HLA-B*39:10-mediated HIV-1 p24 sequence evolution with disease progression.
    Ntale RS; Chopera DR; Ngandu NK; Assis de Rosa D; Zembe L; Gamieldien H; Mlotshwa M; Werner L; Woodman Z; Mlisana K; Abdool Karim S; Gray CM; Williamson C;
    J Virol; 2012 Nov; 86(22):12013-24. PubMed ID: 22933291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.